Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2017 | Advancements in the treatment of prostate cancer

Hilary Baker • 10 Nov 2017
UKONS 2017
Prostate Cancer Radium-223

Prostate cancer therapies have developed greatly in recent years, with many more options for treatment available that can provide patients with a higher quality of life for years after diagnosis. Here, Hilary Baker of University College London Hospitals NHS Foundation Trust, London, UK, summarizes the current strategies available to prostate cancer patients. This interview was recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017 in Harrogate, UK.

More from Hilary Baker

2:03
A streamlined recovery clinic for patients undergoing radical cystectomy at UCLH
Hilary Baker • 10 Nov 2017
1:23
The essential role of the clinical nurse specialist in cancer patient care
Hilary Baker • 10 Nov 2017

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals